Ozempic Pen 0.25 mg contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used in managing type 2 diabetes mellitus. This dose is typically used as the initial starting dose to help patients gradually adapt to the medication, minimizing side effects while beginning to improve blood sugar control. It is administered as a once-weekly subcutaneous injection.

• Provides gentle initiation of Semaglutide therapy

• Helps improve insulin secretion and reduce glucagon release

• Supports early blood glucose control

• Reduces appetite and slows gastric emptying, assisting weight management

• Helps reduce the risk of cardiovascular events in type 2 diabetes patients

• Inject subcutaneously once weekly, on the same day each week

• Injection sites can include the abdomen, thigh, or upper arm

• Rotate injection sites with each dose

• Use the pen exactly as instructed by your healthcare provider

• Starting dose of Ozempic therapy, typically prescribed for 4 weeks before increasing to 0.5 mg or higher

• One injection of 0.25 mg once weekly

• Not for long-term use at this dose alone; dose escalation is usually recommended

• Not indicated for type 1 diabetes or diabetic ketoacidosis

• Contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2

• Use with caution if you have a history of pancreatitis or severe gastrointestinal disease

• Not recommended during pregnancy or breastfeeding

• Report any symptoms such as thyroid nodules or difficulty swallowing to your doctor promptly

• Common side effects may include:

• Nausea or vomiting

• Diarrhea or constipation

• Serious but rare side effects:

• Pancreatitis

• Gallbladder disease

• Kidney problems due to dehydration

• Potential risk of thyroid tumors in animal studies

•  

• Loss of appetite

• Indigestion or abdominal pain

• Store unopened pens in the refrigerator between 2°C and 8°C

• Do not freeze the medication

• Once opened and in use, the pen can be kept at room temperature (up to 30°C) for up to 6 weeks

• Keep away from direct sunlight and out of reach of children

Q1. Why is the 0.25 mg dose important?
The 0.25 mg dose helps patients adjust to Semaglutide, reducing gastrointestinal side effects when starting therapy.

Q2. How long do I stay on this dose?
Usually, this dose is continued for about 4 weeks before increasing to a higher dose for better blood sugar control.

Q3. Can I use Ozempic 0.25 mg alone for diabetes management?
This dose is not intended for long-term control but as an initiation dose to minimize side effects.

Q4. How is Ozempic administered?
It is a once-weekly injection given under the skin in the abdomen, thigh, or upper arm.